TERN News and Press, Terns Pharmaceuticals Inc.

2026-03-05 10:14:13 ET On February 17, 2026, Boxer Capital Management, LLC disclosed a new position in Terns Pharmaceuticals (NASDAQ:TERN) , acquiring 375,000 shares in a transaction estimated at $15.15 million based on quarterly average pricing. Boxer Capital Management, LLC di...

FOSTER CITY, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage oncology company, today announced that members of senior management will be participating in the following upcoming investor c...

2026-02-20 00:22:22 ET According to a SEC filing dated February 17, 2026, ORBIMED Advisors LLC sold 5,409,671 shares of Terns Pharmaceuticals (NASDAQ:TERN) , an estimated $125.01 million transaction based on the average closing price for the quarter ending December 31, 2025. The...

2026-02-17 12:52:00 ET First Turn Management, LLC disclosed a new position in Terns Pharmaceuticals (NASDAQ:TERN) in a February 13, 2026, SEC filing, acquiring 872,049 shares in an estimated $35.23 million trade. According to an SEC filing dated February 13, 2026, First Turn...

2026-02-09 07:04:21 ET from Leerink Partners issued a price target of $58.00 for TERN on 2026-02-09 11:50:35. The adjusted price target was set to $58.00. At the time of the announcement, TERN was trading at $37.73. The overall price target consensus is at $55.38 with hi...

2026-01-12 21:15:58 ET Terns Pharmaceuticals, Inc. (TERN) 44th Annual J.P. Morgan Healthcare Conference January 12, 2026 6:45 PM EST... Read the full article on Seeking Alpha For further details see: Terns Pharmaceuticals, Inc. (TERN) Presents at 44th Annual J.P. Morgan Heal...

CARDINAL Phase 1/2 trial of TERN-701 enrolling well, with multiple important milestones in 2026 Planned milestones include pivotal dose selection, EOP2 regulatory interaction in mid-2026, updated and expanded CARDINAL data by 2H26, and initiation of 2L+ pivotal trial in late 2026/early 2027 ...

2025-12-29 11:00:00 ET Investment Overview The S&P 500 Index ( SPX ) began 2025 trading ~$5,950, and, despite a major downward correction in April - around the time President Donald Trump introduced his retaliatory Liberation Day tariffs on overseas imports into the U.S....

2025-12-22 23:47:10 ET More on healthcare stocks My S&P 500 Prediction On Sector Outperformers And Laggards In 2026 IHI: A Passive ETF For Medical Device Exposure Regencell Bioscience: Material Weaknesses Add To Woes Abivax is the top performing biotechno...

2025-12-22 09:59:33 ET More on healthcare news My S&P 500 Prediction On Sector Outperformers And Laggards In 2026 IHI: A Passive ETF For Medical Device Exposure XLV: The Simple Case For Overweighting U.S. Health Care Year-end sector scorecard: SA Quant-ba...